IL166194A0 - Plasma urotensin in human heart failure - Google Patents

Plasma urotensin in human heart failure

Info

Publication number
IL166194A0
IL166194A0 IL16619403A IL16619403A IL166194A0 IL 166194 A0 IL166194 A0 IL 166194A0 IL 16619403 A IL16619403 A IL 16619403A IL 16619403 A IL16619403 A IL 16619403A IL 166194 A0 IL166194 A0 IL 166194A0
Authority
IL
Israel
Prior art keywords
heart failure
human heart
urotensin
plasma
plasma urotensin
Prior art date
Application number
IL16619403A
Other languages
English (en)
Original Assignee
Inverness Medical Switzerland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0216505A external-priority patent/GB0216505D0/en
Application filed by Inverness Medical Switzerland filed Critical Inverness Medical Switzerland
Publication of IL166194A0 publication Critical patent/IL166194A0/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/5751—Corticotropin releasing factor [CRF] (Urotensin)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL16619403A 2002-07-11 2003-07-11 Plasma urotensin in human heart failure IL166194A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB0216191.7A GB0216191D0 (en) 2002-07-11 2002-07-11 Plasma urotensin in human heart failure
GBGB0216500.9A GB0216500D0 (en) 2002-07-11 2002-07-16 Plasma urotensin in human heart failure
GB0216505A GB0216505D0 (en) 2002-07-11 2002-07-17 Plasma urotensin in human heart failure
PCT/GB2003/003011 WO2004008140A2 (fr) 2002-07-11 2003-07-11 Urotensine plasmique dans une insuffisance cardiaque humaine

Publications (1)

Publication Number Publication Date
IL166194A0 true IL166194A0 (en) 2006-01-15

Family

ID=9940317

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16619403A IL166194A0 (en) 2002-07-11 2003-07-11 Plasma urotensin in human heart failure
IL166194A IL166194A (en) 2002-07-11 2005-01-09 Plasma urotensin in human heart failure

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL166194A IL166194A (en) 2002-07-11 2005-01-09 Plasma urotensin in human heart failure

Country Status (11)

Country Link
US (1) US20040077027A1 (fr)
EP (1) EP1521967B1 (fr)
JP (1) JP4602078B2 (fr)
CN (1) CN100582782C (fr)
AT (1) ATE430937T1 (fr)
AU (1) AU2003281071B2 (fr)
CA (1) CA2492787A1 (fr)
DE (1) DE60327530D1 (fr)
GB (2) GB0216191D0 (fr)
IL (2) IL166194A0 (fr)
WO (1) WO2004008140A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074194B2 (en) * 2003-05-19 2006-07-11 Ischemia Technologies, Inc. Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin
WO2006123253A2 (fr) * 2005-03-29 2006-11-23 Inverness Medical Switzerland Gmbh Dispositif et procede de surveillance d'un patient
EP1722232A1 (fr) * 2005-05-09 2006-11-15 F.Hoffmann-La Roche Ag Dispositifs et procédés de diagnostics ou de prévoir d'un stade précoce des dysfonctionnements cardiaques
EP1910843A2 (fr) * 2005-07-11 2008-04-16 Inverness Medical Switzerland GmbH Analyse
DK2115477T3 (en) * 2007-01-25 2015-08-10 Hoffmann La Roche USE OF IGFBP-7 IN THE EVIDENCE OF HEART FAILURE
CA2680339C (fr) * 2007-03-08 2017-02-28 F. Hoffmann-La Roche Ag Utilisation de slim-1 dans l'evaluation d'une insuffisance cardiaque
EP2347265A1 (fr) * 2008-10-17 2011-07-27 Roche Diagnostics GmbH Utilisation de biglycane dans l évaluation d une insuffisance cardiaque
WO2015175502A2 (fr) * 2014-05-12 2015-11-19 Palatin Technologies, Inc. Traitement de substitution pour les carences en peptides natriurétiques
US12400762B2 (en) 2018-12-11 2025-08-26 Eko.Ai Pte. Ltd. Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and diagnosis of cardiac amyloidosis and hypertrophic cardiomyopathy
US11446009B2 (en) 2018-12-11 2022-09-20 Eko.Ai Pte. Ltd. Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images
US12001939B2 (en) 2018-12-11 2024-06-04 Eko.Ai Pte. Ltd. Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views
US12322100B2 (en) 2018-12-11 2025-06-03 Eko.Ai Pte. Ltd. Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and grading of aortic stenosis severity
US11931207B2 (en) 2018-12-11 2024-03-19 Eko.Ai Pte. Ltd. Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device
EP4767065A1 (fr) * 2023-08-22 2026-07-01 Roche Diagnostics GmbH Surveillance de marqueurs cardiovasculaires dans un liquide interstitiel et son application dans l'évaluation d'une insuffisance cardiaque

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604105B1 (en) * 1990-10-12 1999-08-24 Spectral Diagnostics Inc Method and device for diagnosingand distinguishing chest pain in early onset thereof
US5710008B1 (en) * 1990-10-12 1999-09-07 Spectral Diagnostics Inc Method and device for diagnosing and distinguishing chest pain in early onset thereof
CA2027434C (fr) * 1990-10-12 1999-01-05 George Jackowski Trousse pour le diagnostic des douleurs thoraciques des leur apparition
US6593456B1 (en) * 1996-11-06 2003-07-15 The Regents Of The University Of California Tumor necrosis factor receptor releasing enzyme
US6210976B1 (en) * 1997-06-10 2001-04-03 Medlyte Diagnostics, Inc. Methods for early detection of heart disease
US6075137A (en) * 1998-01-09 2000-06-13 Smithkline Beecham Corporation Human urotensin II
EP1045908A2 (fr) * 1998-01-09 2000-10-25 Smithkline Beecham Corporation Urotensine humaine ii
ATE373826T1 (de) * 1999-01-29 2007-10-15 Roche Diagnostics Gmbh Verfahren zum nachweis von n-terminalem probnp
EP1241479B1 (fr) * 2001-03-12 2007-08-01 Immundiagnostik AG Méthode pour la détermination d'urotensine II dans les fluides corporels et diagnostic des maladies cardiovasculaires

Also Published As

Publication number Publication date
AU2003281071A1 (en) 2004-02-02
IL166194A (en) 2010-11-30
US20040077027A1 (en) 2004-04-22
EP1521967A2 (fr) 2005-04-13
EP1521967B1 (fr) 2009-05-06
ATE430937T1 (de) 2009-05-15
CN1678912A (zh) 2005-10-05
CN100582782C (zh) 2010-01-20
JP2005532564A (ja) 2005-10-27
JP4602078B2 (ja) 2010-12-22
WO2004008140A3 (fr) 2004-05-06
WO2004008140A2 (fr) 2004-01-22
DE60327530D1 (de) 2009-06-18
GB0216500D0 (en) 2002-08-28
GB0216191D0 (en) 2002-08-21
CA2492787A1 (fr) 2004-01-22
AU2003281071B2 (en) 2007-12-13

Similar Documents

Publication Publication Date Title
IL166194A (en) Plasma urotensin in human heart failure
GB0203446D0 (en) Detection and/or monitoring of synuclein-related diseases
GB0329288D0 (en) Monitoring method and apparatus
EP1534358B8 (fr) Ouie d'aspiration au profil bas pour pompe a sang implantable
AU2003256132A8 (en) Automatic blood pressure measuring instrument and method thereof
WO2006006871A3 (fr) Procede et systeme de surveillance de ventilations
AU2003274869A1 (en) A method and an apparatus for determining the efficiency of dialysis
EP2260942A3 (fr) Systeme de prélevement d'échantillion comprennant un inhibiteur de protease
AU2003303287A8 (en) Method of cardiac risk assessment
AU2003214214A8 (en) Method for treating congestive heart failure
WO2004031410A3 (fr) Methode permettant de diagnostiquer des seminomes du testicule
WO2004053497A3 (fr) Procede de prediction de reaction a la therapie dirigee contre le her2
PL373432A1 (en) Method for treating severe heart failure and medicament therefor
EP1774029A4 (fr) Procede pour detecter les risques de diabete non insulino-dependant et pour traiter ce type de diabete
DK1353948T3 (da) Oplöselige biologiske analoge til bata-amyloidpeptid
SI2196545T1 (sl) Postopki za napovedovanje odziva pacientov z multiplo sklerozo na terapijo z interferonom in diagnosticiranje multiple skleroze
EP1540353A4 (fr) Bande d'essai et procede permettant de determiner la concentration du cholesterol ldl a partir d'un echantillon de sang total
NO20072615L (no) Biomarkor for hjertesvikt
GB0200239D0 (en) Method for detecting human papillomavirus mRNA
EP1492880A4 (fr) Procede ex vivo permettant de determiner l'activite de cetp et l'efficacite d'un traitement d'une cardiopathie
ITLE20020017A1 (it) Apparato compiuterizzato per il rivelamento della dinamica articolare.
GB0409153D0 (en) Method of diagnosis
AU2003235111A1 (en) Method of evaluating blood compatibility
AU2003215034A8 (en) Diagnostic method for spectroscopic detection of tuberculosis
GB0208267D0 (en) Methods of monitoring blood pressure